investing

Biotechnology Sector Thrives Amidst Sluggish IPO Market, Caution Advised for Investors

10/28/2026, 11:37 AM investing review biotech

The biotechnology sector is experiencing a surge in initial public offerings (IPOs), contrasting with a broader slowdown in the IPO market, but investors should remain cautious due to the high risks associated with biotech investments.

Analysts highlight Broadcom (AVGO) as a key beneficiary of Anthropic’s upcoming IPO amid rising AI optimism

10/28/2026, 10:37 AM investing review Analysts ai semiconductors Amazon Alphabet Broadcom

Anthropic's upcoming IPO has sparked renewed interest in artificial intelligence stocks, leading to significant gains in related sectors as investors position themselves ahead of the offering, which could be valued between $1.5 trillion and $2 trillion.

Analysts Guggenheim Securities initiate coverage of MSG Rangers (MSGR) and MSG Knickerbockers (MSGK) with buy ratings and significant upside potential

10/28/2026, 08:38 AM investing rating_growth Analysts: analysts, Guggenheim Madison Square Garden Sports

The recent spinoff of the New York Rangers and New York Knicks from Madison Square Garden Sports is expected to create significant value for shareholders, according to Guggenheim Securities, which has issued buy ratings for both teams with substantial price targets.

Analysts Bernstein expects upside for Robinhood Markets (HOOD) with $160 target price driven by prediction markets and new offerings

10/28/2026, 05:37 AM investing forecast Analysts: analysts, Bernstein finance Robinhood

Bernstein predicts significant growth for Robinhood Markets driven by emerging technologies and new products, setting a price target of $160, which suggests a potential upside of 69%. This outlook is particularly relevant as the company adapts to evolving market conditions and regulatory frameworks.

Analysts Jefferies upgraded Chemed (CHE) to Buy and raised target price to $620, expecting 22% upside

10/28/2026, 04:37 AM investing rating_growth Analysts: analysts, Jefferies

Jefferies has upgraded Chemed to a 'buy' rating and increased its price target to $620, indicating a potential 22% upside, following the company's strong third-quarter earnings that exceeded expectations. This upgrade reflects confidence in Chemed's recovery from recent operational challenges and its ability to regain a premium valuation.

Market Movers: Federal Reserve Interest Rate Decision and Earnings Reports from Robinhood, Biogen, and Alphabet Expected

10/27/2026, 04:37 PM investing review Microsoft Robinhood Alphabet Biogen

The upcoming Federal Reserve interest rate decision is a key focus for investors, with significant implications for market movements and bond yields. Additionally, Robinhood's disappointing earnings report has led to a notable decline in its stock price, raising concerns about its future performance.

Analysts expect updates from Oracle, Alphabet, and Amazon to impact AI debt concerns

10/27/2026, 02:39 PM investing forecast Analysts: analysts ai tech Amazon Oracle Alphabet

Recent volatility in AI-related debt markets has subsided, but upcoming earnings reports from major tech companies like Oracle, Alphabet, and Amazon will be critical in shaping investor sentiment and credit spreads.

Investors Prepare for Federal Reserve’s Upcoming Rate Decision Amid Economic Uncertainty

10/27/2026, 02:39 PM investing forecast Analysts: analysts finance energy

Investors are closely monitoring the Federal Reserve's upcoming rate decision, particularly the implications of Chairman Kevin Warsh's comments, as they navigate market opportunities in commodities, energy, and defensive sectors amidst inflation concerns.

JPMorgan’s David Lebovitz Highlights Japan and Europe as Diversification Options Amid AI Stock Volatility

10/27/2026, 11:38 AM investing research finance iShares MSCI Japan ETF iShares Semiconductor ETF

Investors facing concentration risk from the recent downturn in AI stocks may find opportunities in Japan and Europe, which offer diversification and growth potential outside the tech sector.

Analysts Fairlead Strategies note improving momentum for Costco Wholesale (COST) as November approaches

10/27/2026, 08:38 AM investing forecast Analysts: analysts retail Costco

Costco Wholesale's stock is showing signs of improved momentum as it approaches November, a historically strong month for the company, which could signal potential gains for investors.